2016
DOI: 10.1007/s40618-016-0507-8
|View full text |Cite
|
Sign up to set email alerts
|

Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial

Abstract: Supplementation with high-dose vitamin D for 4 months improved vitamin D status and decreased TG levels in subjects with metabolic syndrome. However, it did not have any beneficial effects on other cardiometabolic risk factors; this might be due to the inadequate vitamin D status attained in this study which was conducted in a severely deficient region.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
83
1
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(88 citation statements)
references
References 46 publications
3
83
1
1
Order By: Relevance
“…Our study indicated that vitamin D supplementation did not change the anthropometric indexes, as illustrated in previous studies (Salekzamani et al, ; Sharifi, Amani, Hajiani, & Cheraghian, ; Zittermann et al, ). Although the treatment was not in different seasons (the last month of spring and summer), one of the limitations of this study was seasonal change that can affect the outcome.…”
Section: Discussionsupporting
confidence: 86%
“…Our study indicated that vitamin D supplementation did not change the anthropometric indexes, as illustrated in previous studies (Salekzamani et al, ; Sharifi, Amani, Hajiani, & Cheraghian, ; Zittermann et al, ). Although the treatment was not in different seasons (the last month of spring and summer), one of the limitations of this study was seasonal change that can affect the outcome.…”
Section: Discussionsupporting
confidence: 86%
“…73,74 A recent Iranian study noted that vitamin D supplementation improves vitamin D status and lowers triglyceride levels in patients with MetS. 75 However, a study by George et al demonstrated that vitamin D status is not linked with MetS risk or its components in Black and Indian South Africans, but parathyroid hormone (PTH) is associated with an increased risk of MetS. 33 The association of PTH with MetS was due to its positive correlation with systolic and diastolic blood pressure and waist circumference.…”
Section: Metabolic and Anthropometric Factorsmentioning
confidence: 99%
“…76,77 The association of pro-inflammatory markers and MetS has been confirmed in adolescent Egyptians, 78 but this relationship and the link of other biomarkers with MetS needs to be confirmed in adult sub-Saharan African populations.…”
Section: Metabolic Syndrome In South Africamentioning
confidence: 99%
“…Nagpal et al [27] also found that no improvement was seen in HOMA-IR; however, there was a significant elevation in insulin sensitivity following supplementation with high-dose vitamin D for 6 weeks in healthy obese Indian participants. Supplementation with high-dose vitamin D (50,000 IU/week) for 16 weeks decreased triglycerides levels without change in other cardiometabolic risk factors in participants with metabolic syndrome [28]. However, vitamin D supplementation for ≥6 months has been found to not affect glucose metabolism and lipid profiles among subjects who were overweight [29], obese [30], or older adults [31].…”
Section: Discussionmentioning
confidence: 99%